David Kirn is co-founder and CEO of 4D Molecular Therapeutics (4DMT), a company using directed evolution to invent new adeno-associated virus (AAV) vectors that are tailored to specific target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback